DoW Lupus, Transformative Vision Award

US · MD Dept › of the Army -- USAMRAA (U › S › Army Medical Research Acquisition Activity) grant open #HT942526LRPTVA

Response due Aug 24, 2026 · 00:00 UTC

Summary

The Department of the Army (USAMRAA) is soliciting applications for the Lupus Transformative Vision Award under the Department of Defense (DoD) Congressionally Directed Medical Research Programs (CDMRP). This award is intended to support transformative, high-impact lupus research. The opportunity is posted as a synopsis on Grants.gov and is open for approximately 3.5 months. Specific scope details, funding amounts, and eligibility requirements are not detailed in the synopsis text provided.

What they want

The Lupus Transformative Vision Award (TVA) under the DoD/Army Medical Research Acquisition Activity (USAMRAA) seeks to fund novel and transformative research related to lupus. The award is part of the DoD's lupus research portfolio. Full programmatic requirements, eligibility criteria, and technical specifications are expected to be detailed in a forthcoming Program Announcement or full solicitation document.

How they evaluate

Submission: Grants.gov electronic submission portal

Risks & flags

Synopsis-only posting with no scope details, funding ceiling, or eligibility criteria — full requirements not yet available for competitive assessment
Opportunity number (HT942526LRPTVA) follows USAMRAA CDMRP conventions; award type ('Transformative Vision') may imply a high bar or limited pool of eligible investigators
No stated funding range — makes cost competitiveness assessment impossible at this stage

Market context

inferred from NAICS

Professional, Scientific & Technical Services

NAICS 541711

US market size: $2.0T
Typical award: $25K – $50M

Typical buyers

All federal civilianDoDStates

Commonly required

8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

DoW Lupus, Transformative Vision Award

Due Aug 24

Onboard ↗